6-24445816-T-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001503.4(GPLD1):āc.1836A>Cā(p.Leu612Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000453 in 1,612,264 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001503.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPLD1 | NM_001503.4 | c.1836A>C | p.Leu612Phe | missense_variant | 19/25 | ENST00000230036.2 | NP_001494.2 | |
GPLD1 | XM_017010753.3 | c.1866A>C | p.Leu622Phe | missense_variant | 20/26 | XP_016866242.1 | ||
GPLD1 | XM_047418657.1 | c.1347A>C | p.Leu449Phe | missense_variant | 14/20 | XP_047274613.1 | ||
GPLD1 | XR_007059240.1 | n.2143A>C | non_coding_transcript_exon_variant | 20/27 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPLD1 | ENST00000230036.2 | c.1836A>C | p.Leu612Phe | missense_variant | 19/25 | 1 | NM_001503.4 | ENSP00000230036.1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151846Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251270Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135812
GnomAD4 exome AF: 0.0000479 AC: 70AN: 1460418Hom.: 1 Cov.: 31 AF XY: 0.0000606 AC XY: 44AN XY: 726646
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151846Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74134
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 02, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at